0001140361-20-003647.txt : 20200219
0001140361-20-003647.hdr.sgml : 20200219
20200219163105
ACCESSION NUMBER: 0001140361-20-003647
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200214
FILED AS OF DATE: 20200219
DATE AS OF CHANGE: 20200219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freitag Gregory Gene
CENTRAL INDEX KEY: 0001492710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 20630206
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
CITY: ALACHUA
STATE: FL
ZIP: 32615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDS Biotechnology Corp
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 303A COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 303A COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: Edge Therapeutics, Inc.
DATE OF NAME CHANGE: 20090911
4
1
form4.xml
FORM 4
X0306
4
2020-02-14
0001472091
PDS Biotechnology Corp
PDSB
0001492710
Freitag Gregory Gene
C/O PDS BIOTECHNOLOGY CORPORATION
303A COLLEGE ROAD EAST
PRINCETON
NJ
08540
true
Common Stock
2020-02-14
4
A
0
38400
1.3
A
40271
D
Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on February 14, 2020.
/s/ Gregory Gene Freitag
2020-02-19